iRegene Therapeutics's NouvSight001 Cleared for Clinical Trials in the U.S. and China for Retinitis Pigmentosa – Following its Parkinson’s disease program, iRegene advances another off-the-shelf cell therapy… CISION PRNewswireSeptember 29, 2026
YR Fitness Plans to Expand One-Stop Gym Solutions With Design and Fit-Out Services SHANGHAI, Sept. 29, 2026 /PRNewswire/ — YR Fitness has announced plans to… CISION PRNewswireSeptember 29, 2026
Zoomlion Signs US$300 Million Credit Insurance Policy and Initial US$50 Million Non-Recourse Factoring Agreement SHANGHAI, Sept. 29, 2026 /PRNewswire/ — Zoomlion Heavy Industry Science & Technology Co.,… CISION PRNewswireSeptember 29, 2026
Hengrui Pharma and Novo Enter Exclusive License Agreement for Once-Weekly Oral GLP-1/GIP Dual Receptor Agonist HRS-1596 HRS-1596 is a phase I-ready GLP-1/GIP dual receptor agonist for once-weekly oral… CISION PRNewswireSeptember 29, 2026
Press ReleaseSweden Opens Travel Agency for Introverts New research reveals a growing demand for quieter travel: 67% of travellers prefer… CISION PRNewswireSeptember 29, 2026
Press ReleaseCompanies risk losing their most AI-savvy employees while leaving majority behind: PwC Across the workforce, AI use is up 10 points – but access… CISION PRNewswireSeptember 29, 2026
Press ReleaseKakaopay Securities and Dinari Partner to Expand Global Access to Korean Equities Collaboration will explore the application of Dinari’s tokenization infrastructure to Korean-listed equities… CISION PRNewswireSeptember 29, 2026
SEMIFIVE Secures USD 52 Million AI Accelerator Contract with U.S. Fabless Company, Validating End-to-End ASIC Model in North America First Spec Hand-off project in North America marks SEMIFIVE’s largest single contract… CISION PRNewswireSeptember 29, 2026